Back to the main directory
Press Release
- Kallelse till Aktia Bank Abp:s ordinarie bolagsstämma 2025 by GlobeNewsWire
- BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Increases Full Year 2025 Guidance by GlobeNewsWire
- Lulus Unveils New Brand Campaign to Expand Market Presence and Deepen Customer Loyalty by GlobeNewsWire
- Man Group PLC : Form 8.3 - Dowlais Group plc by GlobeNewsWire
- Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings Inc by GlobeNewsWire
- Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024 by BusinessWire
- Tyson Ventures Calls Startups to Apply for Tyson Demo Day 2025 by GlobeNewsWire
- GFG Signs Exploration Agreement with Apitipi Anicinapek Nation by GlobeNewsWire
- Lands' End Announces Fourth Quarter and Fiscal 2024 Earnings Conference Call by GlobeNewsWire
- AirSculpt Technologies Announces Fourth Quarter Fiscal 2024 Earnings Release Date and Conference Call by GlobeNewsWire
- HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements by GlobeNewsWire
- IREN February 2025 Monthly Update by GlobeNewsWire
- Autolus Therapeutics to Report Fourth Quarter 2024 Financial Results and Host Conference Call on March 20, 2025 by GlobeNewsWire
- Conavi Medical Announces Uplisting to OTCQB Venture Market by GlobeNewsWire
- Enthusiast Gaming Launches New Season of its Content Creator Competition, Rising Stars by GlobeNewsWire
- G-III Apparel Group Announces Date for Fourth Quarter and Full Year Fiscal 2025 Results by GlobeNewsWire
- Sachem Capital Corp. Announces Dividend of $0.05 Per Share by GlobeNewsWire
- AYR Wellness Reports Fourth Quarter and Full Year 2024 Results by GlobeNewsWire
- Clearside Biomedical Announces Successful End-of-Phase 2 Meeting with the FDA and Alignment on Phase 3 Plans for Suprachoroidal CLS-AX in Wet AMD by GlobeNewsWire
- Viasat and partners deliver first-of-its-kind direct-to-device demonstration in South America by GlobeNewsWire
- Monro, Inc. to Participate at the 2025 UBS Global Consumer and Retail Conference by BusinessWire
- Plus Therapeutics Granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the Treatment of Leptomeningeal Metastases in Patients with Lung Cancer by GlobeNewsWire
- Macerich Advances HiFi, Outdoor Mixed-Use Development at FlatIron Crossing in Colorado, Names Entertainment Anchor by GlobeNewsWire
- Currency Exchange International to Report its First Quarter 2025 Results on March 12, 2025, and Host Earnings Conference Call on March 13, 2025 at 8:30 AM EST by GlobeNewsWire
- Altimmune to Host Virtual R&D Day on March 13, 2025 by GlobeNewsWire